3-Carbethoxypsoralen
CAS : 20073-24-9
Ref. 3D-VAA07324
1mg | Arrêté | ||
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté |
Informations sur le produit
- ((6-Hydroxy-5-benzofuranyl)methylene)malonic acid, gamma-lactone, ethyl ester
- 3-CPs
- 3-Ethoxycarbonylpsoralen
- 7-Oxo-7H-furo(3,2-g)(1)benzopyran-6-carboxylic acid ethyl ester
- 7H-Furo(3,2-g)(1)benzopyran-6-carboxylic acid, 7-oxo-, ethyl ester
- Brn 0278285
- Ethyl 3-psoralencarboxylate
- Ethyl furo[3,2-g]coumarin-3-carboxylate
- ethyl 7-oxo-7H-furo[3,2-g]chromene-6-carboxylate
3-Carbethoxypsoralen is a potent inducer of DNA damage by interacting with the nuclear DNA. It also has a role in the transfer reactions between 8-methoxypsoralen and 3-hydroxypsoralen, which are responsible for the photochemical activity of these compounds. 3-Carbethoxypsoralen has been shown to be genotoxic and mutagenic in both wild-type and mutant strains of Escherichia coli. 3-Carbethoxypsoralen is also an effective inhibitor of protein synthesis, as well as being a potent inducer of biochemical properties including cell death. This drug is used in the treatment of infectious diseases, such as herpes simplex virus type 1 (HSV-1) and varicella zoster virus (VZV).